Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Yuichi Kudaka"'
Autor:
Masaaki Takahashi, Naoto Mamiya, Shiro Ibe, Naoya Okumura, Tsuguhiro Kaneda, Motohiro Hamaguchi, Tatsuo Suzuki, Yuichi Kudaka, Atsushi Hirano
Publikováno v:
AIDS Research and Human Retroviruses. 23:983-987
The present study assessed the relationship between central nervous system (CNS) side effects and plasma concentrations of efavirenz (EFV) in Japanese HIV-1-infected patients. Subjects consisted of 69 HIV-1-infected patients (57 therapy-naive and 12
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fb528059c48c392f17ac1768ce12b9e9
https://doi.org/10.1089/aid.2006.0193
https://doi.org/10.1089/aid.2006.0193
Autor:
Naoya Okumura, Atsushi Hirano, Yuichi Kudaka, Kazuhide Banno, Masaaki Takahashi, Tsuguhiro Kaneda, Mitsuru Konishi, Nami Terahata
Publikováno v:
Biologicalpharmaceutical bulletin. 31(8)
Raltegravir belongs to a new class of antiretrovirals acting for a human immunodeficiency virus (HIV)-1 integrase inhibition. Clinical trials of this drug have demonstrated potent antiviral activity in both therapy naïve and experienced patients. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9a56fafeebefa980bb645ca83422ab5
https://pubmed.ncbi.nlm.nih.gov/18670096
https://pubmed.ncbi.nlm.nih.gov/18670096
Autor:
Masaaki Takahashi, Naoya Okumura, Yuichi Kudaka, Kazuhide Banno, Tsuguhiro Kaneda, Atsushi Hirano
Publikováno v:
Biologicalpharmaceutical bulletin. 30(10)
Darunavir (DRV) is a new protease inhibitor used to treat human immunodeficiency virus (HIV) type-1. The aim of this study was to validate the determination of plasma DRV concentrations using the HPLC method, a simple procedure for simultaneous deter
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::53c213ad79ee42be4b13b852d5622902
https://pubmed.ncbi.nlm.nih.gov/17917268
https://pubmed.ncbi.nlm.nih.gov/17917268
Autor:
Tsuguhiro Kaneda, Naoya Okumura, Masaaki Takahashi, Yuichi Kudaka, Atsushi Hirano, Kazuhide Banno
Publikováno v:
Biologicalpharmaceutical bulletin. 30(9)
The quantification of tenofovir, a nucleoside reverse transcriptase inhibitor prescribed once daily, in human plasma is important due to a recent increase in its use. HPLC, however, can not easily detect and quantify tenofovir because of interfering
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8e2c13c5b1a4595d97ea20b6b81ec84d
https://pubmed.ncbi.nlm.nih.gov/17827740
https://pubmed.ncbi.nlm.nih.gov/17827740
Autor:
Tsuguhiro Kaneda, Kazuhide Banno, Naoya Okumura, Yuichi Kudaka, Atsushi Hirano, Masaaki Takahashi
Publikováno v:
AIDS Research and Human Retroviruses. 24:114-115
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09b26b026a86f831cb3cc9c165d80135
https://doi.org/10.1089/aid.2007.0176
https://doi.org/10.1089/aid.2007.0176
Autor:
Masaaki Takahashi, Yuichi Kudaka, Naoya Okumura, Atsushi Hirano, Kazuhide Banno, Tsuguhiro Kaneda
Publikováno v:
AIDS Research & Human Retroviruses; Jan2008, Vol. 24 Issue 1, p114-115, 2p